Compare Dollar Tree, Inc. (DLTR) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dollar Tree, Inc. vs Smith & Nephew plc — how do they compare? Dollar Tree, Inc. trades at $127.65 (market cap $24.86B), while Smith & Nephew plc trades at $30.05 (market cap $12.50B). The key difference: Dollar Tree, Inc. is the larger of the two by market cap, and Smith & Nephew plc pays a 2.64% dividend while Dollar Tree, Inc. pays none. Which is the better fit depends on your goals.
| DLTR | SNN | |
|---|---|---|
Market Cap | $24.86B | $12.50B |
Sector | Health | Health |
52-Week High | $141.21 | $38.70 |
52-Week Low | $85.04 | $28.73 |
Enterprise Value | $31.45B | $15.53B |
Dividend Yield | — | 2.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dollar Tree, Inc.
Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.
Read more on DLTR →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
